We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




New Test Developed to Diagnose Virulent Lung Fungus

By LabMedica International staff writers
Posted on 04 Aug 2014
The emergence of distinct populations of Cryptococcus gattii in the temperate North American Pacific Northwest (PNW) was surprising, as this species was previously thought to be confined to tropical and semitropical regions.

C. More...
gattii, is a pathogenic fungus that is highly adaptive and warrants global public health vigilance, and the dominant emergent population displays increased virulence and caused primary pulmonary disease, as opposed to the predominantly neurologic disease seen previously elsewhere.

Scientists at Northern Arizona University (Flagstaff, AZ, USA) working with an international team from 15 countries performed whole-genome sequencing on 118 C. gattii isolates, including the PNW subtypes and the global diversity of molecular type VGII, to better ascertain the natural source and genomic adaptations leading to the emergence of infection in the PNW.

The genomes of all 118 C. gattii isolates were sequenced using HiSeq, MiSeq, or GAIIx sequencing technology (Illumina; San Diego, CA, USA). High-molecular-weight DNA was extracted using the ZR Fungal/Bacterial DNA MiniPrep kit (Zymo Research; Irvine, CA, USA). Prior to sequencing, the libraries were quantified with quantitative PCR (qPCR) on the ABI 7900HT (Life Technologies Corporation; Carlsbad, CA, USA). Single nucleotide polymorphisms variant detection, multilocus sequence typing (MLST), and phylogenetic analysis were also performed.

The team found that there were most likely multiple distinct North American introductions of at least two of the three PNW VGII subtypes. Gene content varies between the VGII subtypes and C. gattii has developed a number of evolutionary strategies that allow for continual niche adaptation. Paul Keim, PhD, one of the study's senior authors, said “By closely analyzing the genomes of dozens of outbreak strains, as well as globally diverse strains, we were able to closely compare and determine the genomic differences that may cause their clinical and ecological changes.”

The new tests developed for this study by the Translational Genomics Research Institute (Flagstaff, AZ, USA) are making it easier to detect this and other fungi, and could lead to better monitoring and treatments. The same tools used in this study were also used to investigate the cause of a fungal meningitis outbreak associated with steroid back injections, and the recent outbreak of Valley Fever. The study was published on July 15, 2014, in the journal mBIO.

Related Links:

Northern Arizona University 
Illumina
Zymo Research



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Automatic Western Blot Analyzer
Tenfly Phoenix Blot Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.